Solid Biosciences Reports Positive Initial Clinical Data from INSPIRE DUCHENNE Trial Regeneron Reports 10/11 Children with Otoferlin-related hearing loss in the CHORD Trial Demonstrate Notable Hearing Improvements MeiraGTx reports that all 11 children with LCA4 gained visual acuity after receiving the investigational genetic medicine Fuse Vectors has raised $5.2 million in pre-seed funding to accelerate the development of its cell-free viral vector technology

FULL event agenda

Get your version of the full event agenda to see the complete speaker faculty, details of our morning mastermind sessions, and how to make the most of our group discounts.

WHAT CAN YOU EXPECT?

  • Network With Leading Technical Experts from CSL Behring, Alector, Sanofi, and more!
  • Attend Interactive Morning Masterminds designed to forge cross-functional connections
  • Hear Real-World Guidance on the new FDA potency guidelines
  • Delve Into AI & Automation for precise assay quantification utilizing closed systems
3rd Gene Therapy Potency Assay Summit | 28-29 May, 2025

Having issues downloading the brochure? Let us know and we'll email it to you instead.

Previously Attending Companies Include:

59847 - Website Banner